{
    "root": "e26f6689-32e5-4e89-b53b-64f99b65e25d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "gabapentin",
    "value": "20250509",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B"
        },
        {
            "name": "HYPROMELLOSE 2208 (100000 MPA.S)",
            "code": "VM7F0B23ZI"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE"
        },
        {
            "name": "POLYETHYLENE GLYCOL 7000000",
            "code": "G3MS6M810Y"
        },
        {
            "name": "POVIDONE K90",
            "code": "RDH86HJV5Z"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "Gabapentin tablet is indicated for the management of postherpetic neuralgia.\n                  Once-daily gabapentin tablets are not substitutable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration.",
    "contraindications": "Gabapentin tablet should be titrated to an 1,800 mg dose taken orally, once-daily with the evening meal. Gabapentin tablets should be swallowed whole. Do not crush, split or chew the tablets. ( 2.1 ) If gabapentin dose is reduced, discontinued, or substituted with an alternative medication, this should be done gradually over a minimum of 1 week or longer (at the discretion of the prescriber). ( 2.1 ) Renal impairment: Dose should be adjusted in patients with reduced renal function. Gabapentin tablet should not be used in patients with CrCl less than 30 or in patients on hemodialysis. ( 2.2 )",
    "warningsAndPrecautions": "Gabapentin Tablets, 300 mg are white to off-white, oval, film-coated tablets debossed with \"608\" on one side and plain on the other side and are supplied as follows:\n                  NDC 68382-608-16 in bottle of 90 tablets with child-resistant closure\n                  NDC 68382-608-05 in bottle of 500 tablets\n                  NDC 68382-608-77 in unit-dose blister cartons of 100 (10 x 10) unit dose tablets\n                  Gabapentin Tablets, 600 mg are white to off-white, oval, beveled edge film coated tablets debossed with \"607\" on one side and plain on the other side and are supplied as follows:\n                  NDC 68382-607-16 in bottle of 90 tablets with child-resistant closure\n                  NDC 68382-607-05 in bottle of 500 tablets\n                  NDC 68382-607-77 in unit-dose blister cartons of 100 (10 x 10) unit dose tablets\n                  \n                     Storage\n                  \n                  Store at 20° C to 25°C (68° F to 77°F); excursions permitted to 15ºC to 30ºC (59ºF to 86ºF) [See USP Controlled Room Temperature].\n                  Keep out of reach of children.",
    "adverseReactions": "Gabapentin tablet is contraindicated in patients with demonstrated hypersensitivity to the drug or its ingredients."
}